Week 1 - Biotech Bears Out to Eat…
Public Biotech in Free Fall, Private Biotech Quite Ahead of JPM
Hello Avatar! Welcome back for another week of biotech analysis. You will note a significant change to our format this week as we move to bi-weekly updates. Go-forward, the Thursday newsletter will be an update focused on the public and private markets. On the public side we aim to provide content from the analyst community that is not as broadly cov…
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.